Related Experiment Video
Updated: May 17, 2026
04:01
Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
Published on: September 15, 2023
Papillary thyroid carcinoma in a thyroglossal cyst
Ravi Ramalingam1, K K Ramalingairr, A V Ramesh
1Chinnammal ENT Hospital, Chennai, Noombal.
Summary
Papillary thyroid carcinoma is rarely found within a thyroglossal duct cyst. Sistrunk's operation is crucial for removing the cyst and managing any incidental papillary thyroid carcinoma, ensuring no metastasis.
Area of Science:
- Endocrinology
- Surgical Oncology
- Pathology
Background:
- Thyroglossal duct cysts are common congenital anomalies.
- Papillary thyroid carcinoma (PTC) arising within a thyroglossal duct cyst is exceptionally rare, with fewer than 160 cases reported historically.
- This rarity poses diagnostic and management challenges.
Purpose of the Study:
- To report a case of papillary thyroid carcinoma incidentally discovered within a thyroglossal duct cyst.
- To highlight the role of Sistrunk's operation in the management of such cases.
- To discuss the oncological implications and follow-up strategies.
Main Methods:
- A case presentation of a patient with a thyroglossal duct cyst.
- Surgical excision using Sistrunk's operation.
- Histopathological examination of the excised cyst.
- Post-operative management including thyroid suppression therapy and follow-up.
Main Results:
- Papillary thyroid carcinoma was identified within the thyroglossal duct cyst post-excision.
- No evidence of metastasis to the thyroid gland or regional lymph nodes was found.
- The patient received thyroxine for thyroid suppression.
- One-year follow-up revealed no signs of recurrence or metastasis.
Conclusions:
- Sistrunk's operation is essential for complete thyroglossal duct cyst removal and provides access for diagnosing incidental PTC.
- Early diagnosis and appropriate management, including thyroid suppression, are vital for favorable outcomes in these rare cases.
- Complete surgical excision and vigilant follow-up are key to preventing metastasis.
Related Concept Videos
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...